Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 6 minute read Pharma Industry News Technology News IM Cannabis to acquire 60% stake in quantum bio-data firm in up to US$54m deal Find out how IM Cannabis is entering the quantum computing bio-data space—and what it could mean for investors and the company’s next growth phase. bySoujanya RaviOctober 23, 2025